A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/19 (2006.01)
Patent
CA 2057034
Onset-hastened and enhanced antipyretic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering from elevated body temperature (fever), by administering thereto a unit dosage onset-hastening/enhancing antipyretically effective amount of the S(+) ibuprofen enantiomer, said enantiomer being substantially free of its R(-) ibuprofen antipode.
On produit une réponse antipyrétique plus forte et se déclenchant plus vite dans l'organisme d'un mammifère nécessitant un tel traitement, c'est-à-dire un mammifère souffrant d'une élévation de la température du corps (fièvre), en lui administrant une dose unitaire d'une quantité efficace, augmentant et déclenchant plus vite la réponse antipyrétique, de l'énantiomère d'ibuprofen S(+), cet énantiomère étant sensiblement exempt de son antipode d'ibuprofen R(-).
Laska Eugene M.
Sunshine Abraham
Sterling Drug Inc.
Swabey Ogilvy Renault
LandOfFree
Onset hastened/enhanced antipyretic response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Onset hastened/enhanced antipyretic response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Onset hastened/enhanced antipyretic response will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1841823